| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.025 | 0.9 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.023 | 0.9 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.021 | 0.9 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.0066 | 0.9 |